Research
What’s happening in your head?
The science behind the things people describe, from a shift in how the world looks to a change in how they feel about themselves.
What can a brain scan actually tell us?
A scan can show changes in brain activity during an experience. To know how that experience felt, researchers still have to ask the person who had it.
Why do researchers ask people to rate a trip?
A rating gives researchers a way to compare answers across people. An account in someone’s own words can still tell you things the score leaves out.
Let’s talk about
psychedelics.
The compounds, the science, and what people actually experience. All in one place.
Compounds
Browse the
guides.
Experiences
What it can
feel like.
Community
Stories and open
discussion.
Our mission
We’re here to break the taboo around psychedelics and give people one place to learn, share experiences, and understand the risks.
Compounds
Classic psychedelics
These are some of the best-known psychedelics. They can change how things look and sound, how time feels, and how you think.
Other psychedelics
This group brings together plant preparations like ayahuasca, naturally occurring compounds like 5-MeO-DMT, and lab-made ones like 2C-B.
Shulgin compounds
Dissociatives
Dissociatives can make you feel detached from your body or surroundings. Ketamine is a familiar example.
Other hallucinogens
Compounds beyond the classic psychedelics: MDMA is an empathogen associated with emotional connection; salvia can profoundly alter perception.
Psilocybin
The principal psychedelic in psilocybin mushrooms
A familiar world, seen and felt in unfamiliar ways.
Psilocybin occurs in many species of psychedelic mushrooms. The body converts it into psilocin, which produces most of its effects.
Its place in contemporary culture spans personal exploration, Indigenous traditions and clinical research. These settings share a compound, but not necessarily the same intentions or experience.
Psilocybin at a glance
- Family
- Tryptamines
- Type
- Classic psychedelic
- Primary target
- 5-HT2A, through psilocin
- Onset (oral)
- Usually 20–60 minutes
- Duration (oral)
- About 4–6 hours
- Origin
- Certain mushrooms
What is Psilocybin?
Psilocybin is a naturally occurring tryptamine. After conversion to psilocin, it acts at serotonin receptors, particularly 5-HT2A, changing how perception, emotion and thought are organised.
A mushroom is not a standardised quantity of psilocybin. Species, individual specimens and storage can all affect its composition. Research with measured psilocybin is therefore different from research with whole mushrooms.
The Psilocybin experience
Sensory effects
Colours and textures may become unusually vivid. Patterns can seem to breathe, and closed-eye imagery may develop into intricate shapes or scenes.
Music can feel more layered or emotionally absorbing. Some people describe synaesthesia, such as sounds seeming to have colour; these temporary experiences need not resemble lifelong synaesthesia.
Body sensations
The body may feel light, heavy or unusually sensitive. Nausea and other physical discomfort can occur alongside pleasant sensations, and bodily feelings may change during the experience.
Headspace
Thoughts often become more associative. Memories, relationships and familiar habits can acquire new significance. Laughter, tenderness and connection may alternate with sadness, uncertainty or fear.
Self, time and space
Time may feel stretched or difficult to follow. At greater intensity, the boundary between self and surroundings can soften, sometimes described as ego dissolution. A powerful feeling of meaning is not the same as a factual conclusion.
History and culture
Psychedelic mushrooms have longstanding ceremonial roles among Indigenous peoples in Mexico. These are living traditions, with their own languages, practices and meanings.
Albert Hofmann isolated psilocybin and psilocin in the 1950s. Wider Western interest brought research and popular attention, but also disruption and appropriation of the communities whose practices attracted that attention.
Research and uses
Clinical studies have investigated psilocybin with psychological support for depression and other conditions. Results have encouraged larger trials, but outcomes depend on the people studied, the support provided and how improvement is measured.
Research also explores changes in perception and brain activity. These studies do not establish that every mushroom experience is therapeutic, or that a meaningful experience necessarily produces lasting benefit.
Risks and considerations
Anxiety, confusion, nausea and temporary increases in blood pressure can occur. Altered judgement can create a risk of injury, and particular mental-health vulnerabilities may make the experience less predictable.
Whole mushrooms introduce an additional issue: misidentification can cause serious poisoning. Persistent perceptual disturbances are reported with psychedelics, although their frequency and causes remain uncertain.
FAQ
Is psilocybin the same as psilocin?
No. They are closely related; psilocybin is converted into psilocin in the body.
Does natural mean safer?
No. Origin does not determine safety, and mushroom potency is variable.
Is it always a spiritual experience?
No. People describe many kinds of experience, including ordinary, playful, difficult or confusing ones.
LSD
Lysergic acid diethylamide
A long unfolding shift in perception, thought and the sense of self.
LSD is a potent psychedelic associated with vivid sensory changes and unusually fluid patterns of thought. It belongs to the lysergamide family.
Its long duration gives an experience room to change character repeatedly, from playful attention to detail to deep absorption in ideas, emotions or surroundings.
LSD at a glance
- Family
- Lysergamides
- Type
- Classic psychedelic
- Primary target
- 5-HT2A
- Onset (oral)
- Usually 30–90 minutes
- Duration (oral)
- About 8–12 hours
- Origin
- Semi-synthetic
What is LSD?
LSD acts on several serotonin receptors, with 5-HT2A central to its psychedelic effects. Its pharmacology also involves other receptor systems, so describing it as simply increasing serotonin would be misleading.
It is made from a chemical starting point related to ergot alkaloids. LSD itself is not a mushroom or a naturally occurring plant preparation.
The LSD experience
Sensory effects
Surfaces may ripple, colours appear saturated and ordinary details develop intricate patterns. Visual changes can range from subtle movement to immersive imagery.
Sound may become unusually absorbing or seem connected with visual patterns. Synaesthesia, such as sounds appearing to have colour, is reported; research distinguishes these temporary effects from consistent lifelong synaesthesia.
Body sensations
People describe changes in bodily sensitivity, energy and tension. Physical restlessness or discomfort can accompany an otherwise enjoyable experience, and stimulation may persist as the main effects ease.
Headspace
Attention can move rapidly between associations or become absorbed in one thought. Humour, wonder and emotional openness may give way to anxiety or repetitive thought loops. The headspace can change repeatedly over the course of the experience.
Self, time and space
Time can feel slowed, expanded or difficult to estimate. The distinction between self and surroundings may become less clear, with experiences ranging from unusual connectedness to ego dissolution.
History and culture
Albert Hofmann first synthesised LSD in 1938 and recognised its psychedelic effects in 1943. Early psychiatric research preceded its much wider cultural visibility.
During the 1960s, LSD became linked with music, art, counterculture and arguments about consciousness and social change. That cultural legacy remains influential, alongside renewed clinical investigation.
Research and uses
LSD has been studied as a way to understand perception and consciousness and as a possible aid in psychotherapy. Contemporary studies include work on anxiety and other mental-health conditions.
Its effects can make blinding difficult: participants often know whether they received a psychedelic. Expectations and the treatment setting therefore matter when interpreting promising results.
Risks and considerations
Its long duration can make distress exhausting. Panic, confusion, impaired judgement and temporary cardiovascular changes are possible, and sleep may remain difficult after the main effects subside.
Persistent visual symptoms and severe psychiatric reactions are reported, particularly in vulnerable individuals. A name or appearance cannot establish the identity of an unregulated product.
FAQ
Is LSD the same as acid?
Acid is a common name for LSD, but a street name does not verify a product’s contents.
Are all LSD experiences visual?
No. Changes in thought, emotion and time can be as prominent as visual effects.
Does microdosing have established benefits?
Strong claims exceed the evidence. Expectation effects and inconsistent study methods complicate the picture.
DMT
N,N-Dimethyltryptamine
An extraordinarily powerful compound capable of profoundly altering perception, consciousness and our experience of reality.
DMT, or N,N-dimethyltryptamine, is a naturally occurring psychedelic found in a variety of plants and detected in mammals, including humans.
It is particularly remarkable for the intensity of its effects and, when inhaled, their unusually short duration. Within moments, familiar surroundings can give way to intricate geometric patterns, extraordinary landscapes and experiences that seem to transcend ordinary perception.
DMT at a glance
- Family
- Tryptamines
- Type
- Classic psychedelic
- Primary target
- 5-HT2A
- Onset (inhaled)
- Within seconds
- Duration (inhaled)
- 5–20 minutes
- Origin
- Plants and mammals
What is DMT?
DMT belongs to the tryptamine family and resembles serotonin, a chemical messenger involved in mood, perception and thought. Its psychedelic effects are strongly associated with activating 5-HT2A receptors. It also acts at other receptors, and no single receptor explains the full experience.
The body breaks DMT down rapidly, mainly through an enzyme called monoamine oxidase A (MAO-A). This helps explain its short duration when inhaled. Preparations containing MAO inhibitors, such as ayahuasca, change how it is processed and can produce much longer effects.
DMT occurs in plants including Psychotria viridis and Mimosa tenuiflora, and has been detected in humans and other mammals. What it does naturally in the human body remains uncertain; its presence does not mean it normally produces psychedelic effects.
Its chemical formula is C₁₂H₁₆N₂, with a molecular mass of 188.27 g/mol.
The DMT experience
Sensory effects
Colours can become vivid and surfaces fill with shifting geometry. More immersive experiences may replace the familiar world with tunnels, chambers or elaborate landscapes. Some people describe apparently independent beings; the vividness of an encounter does not establish that it exists outside the experience.
Sound may seem altered or become part of the unfolding scene. Accounts include perceived tones or buzzing, although auditory effects are less consistently described than visual ones.
Body sensations
The onset can bring intense bodily sensations and a rapid change in awareness of the body. Familiar physical boundaries may become difficult to locate, or bodily awareness may fade altogether.
Headspace
Wonder, joy and connection can occur alongside fear, confusion or a sense of being overwhelmed. Experiences may feel deeply significant while remaining difficult to remember or interpret afterwards. Intensity alone does not make an insight true.
Self, time and space
The sense of being a separate person can diminish or disappear, often described as ego dissolution. Personal history and ordinary surroundings may become remote. Minutes can feel enormously extended, or time may seem to lose its meaning.
History and culture
Canadian chemist Richard Manske first synthesised DMT in 1931, before its psychedelic properties were understood. Brazilian researcher Oswaldo Gonçalves de Lima identified it in plant material in 1946. These scientific milestones came long after traditions involving DMT-containing plants.
In 1956, Hungarian psychiatrist and chemist Stephen Szára documented its psychedelic effects in humans. During the 1990s, Rick Strassman conducted controlled studies of its psychological and physiological effects. His later book, DMT: The Spirit Molecule, brought that work to a wider audience.
Research and uses
Researchers use DMT to study perception and consciousness, while clinical trials are exploring possible therapeutic uses. These are different kinds of research: understanding an experience does not establish a medical treatment.
Brain activity. A 2023 study combined brain imaging and electrical recordings in 20 healthy volunteers receiving intravenous DMT. Researchers observed increased communication across the brain and less separation between some networks. This helps describe what changes during the experience, but does not yet explain why particular images or sensations arise.
Entity encounters. A 2020 survey examined accounts from 2,561 people who reported encounters with apparent beings after inhaled DMT. Many described lasting personal meaning or changes in belief. Because participants were selected for having these encounters, the findings cannot tell us how common they are among all DMT users.
Depression. A small phase IIa trial published in Nature Medicine in February 2026 studied intravenous DMT with psychological support in 34 adults with moderate-to-severe depression. Symptoms improved more with DMT than placebo at two weeks. The result is promising, but larger studies are needed to establish effectiveness, longer-term outcomes and safety. DMT is not an established treatment for depression.
Risks and considerations
A short experience can still be overwhelming. DMT's rapid onset can bring intense anxiety, panic, confusion or distress. Losing awareness of ordinary surroundings also creates a risk of accidental injury.
DMT can temporarily raise heart rate and blood pressure. Interactions with medications and other compounds can add risks, and people vulnerable to psychosis may face particular concerns. Research on longer-term outcomes remains limited.
Clinical studies use screening, controlled environments and medical supervision. Their findings should not be taken as evidence that unsupervised use carries the same risks. DMT is also controlled in many countries, with legal status varying by jurisdiction.
FAQ
Is DMT the same as 5-MeO-DMT?
No. They are related but distinct compounds, with different effects and pharmacology. Their names should not be treated as interchangeable.
Does the body release DMT during dreams or at death?
This is a popular theory, but it has not been demonstrated in humans. There is no convincing evidence that the human brain releases psychedelic quantities of DMT during these events.
Is DMT addictive?
DMT is not generally associated with physical dependence or the compulsive patterns seen with many addictive drugs. That does not rule out problematic use, and research on long-term use remains limited.
Sources
- Barker (2018). N,N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.
- Timmermann et al. (2023). Human Brain Effects of DMT Assessed via EEG-fMRI.
- Davis et al. (2020). Survey of Entity Encounter Experiences Occasioned by Inhaled N,N-Dimethyltryptamine.
- Nichols (2018). N,N-Dimethyltryptamine and the Pineal Gland: Separating Fact from Myth.
- A Short-Acting Psychedelic Intervention for Major Depressive Disorder (2026). Nature Medicine.
Mescaline
3,4,5-Trimethoxyphenethylamine
A long-lasting psychedelic with deep roots in cactus traditions.
Mescaline is found in cacti including peyote and San Pedro. It is a classic psychedelic, but chemically it belongs to a different family from DMT and psilocybin.
Learning about mescaline also means recognising that a purified compound, a cactus and a ceremonial tradition are related but distinct subjects.
Mescaline at a glance
- Family
- Phenethylamines
- Type
- Classic psychedelic
- Primary target
- 5-HT2A
- Onset (oral)
- Often 1–2 hours
- Duration (oral)
- About 8–14 hours
- Origin
- Certain cacti
What is Mescaline?
Mescaline is a phenethylamine whose psychedelic effects are associated with 5-HT2A receptors. A different chemical family does not mean an entirely different kind of experience: several classic psychedelics converge on this receptor.
Cacti contain other compounds as well, and their composition varies. A controlled study of mescaline cannot fully describe every cactus preparation or ceremonial setting.
The Mescaline experience
Sensory effects
Accounts describe enhanced colour, patterned vision and changes in how objects and distances appear. Comparisons with other psychedelics vary considerably between people.
Music and other sounds may feel unusually rich or meaningful. Synaesthesia, including sound seeming to evoke colour, is reported, but is not a defining or universal feature.
Body sensations
The experience can have a noticeable physical presence. Nausea is common, particularly with cactus preparations, while bodily sensations may range from warmth and sensitivity to discomfort.
Headspace
Emotional warmth and connection feature in many accounts, alongside reflection and sustained attention to surroundings. Anxiety or difficult emotions can also arise; a reputation for gentleness does not predict an individual response.
Self, time and space
The gradual onset and long duration can change the sense of how time is passing. Familiar boundaries between self and environment may soften, although the degree of change varies widely.
History and culture
Peyote and San Pedro belong to distinct Indigenous traditions in North and South America. Their ceremonial significance cannot be reduced to their mescaline content.
Arthur Heffter isolated mescaline in the late nineteenth century. It later entered experimental psychology and Western literature, including Aldous Huxley’s account in The Doors of Perception.
Research and uses
Controlled research investigates mescaline’s effects on mood, perception and physiological measures, including comparisons with other psychedelics. Its modern clinical evidence base is smaller than psilocybin’s.
Reports of lasting personal benefit raise useful questions, but do not by themselves demonstrate an effective treatment. Cultural use and medical evidence answer different questions.
Risks and considerations
Nausea, anxiety and increases in heart rate or blood pressure can occur. Its extended duration can make a difficult experience tiring and prolonged.
Peyote also raises conservation and cultural concerns. Demand for wild plants can affect ecosystems and Indigenous access; interest in the compound should not erase those consequences.
FAQ
Is mescaline the same as peyote?
No. Mescaline is one compound found in peyote and several other cacti.
Is it related to 2C-B?
Both are phenethylamines, but they are distinct compounds with different effects and duration.
Is it always gentler than LSD?
No. Descriptions such as gentle are subjective and do not predict intensity or safety.
Ayahuasca
A family of Amazonian plant preparations
A psychedelic experience shaped by plants, people and ceremony.
Ayahuasca refers to preparations with roots in Indigenous Amazonian traditions, commonly combining the Banisteriopsis caapi vine with a DMT-containing plant. Recipes and practices vary.
Unlike the other compound names here, ayahuasca does not identify one molecule. Its effects come from a combination of constituents and a particular cultural and personal setting.
Ayahuasca at a glance
- Family
- Mixed plant alkaloids
- Type
- Psychedelic preparation
- Primary target
- 5-HT2A; MAO-A inhibition
- Onset (oral)
- Often 20–60 minutes
- Duration (oral)
- About 4–6 hours
- Origin
- Amazonian plant traditions
What is Ayahuasca?
DMT produces psychedelic effects through serotonin receptors, including 5-HT2A. Alkaloids in the vine, including harmine and harmaline, inhibit MAO-A, an enzyme that normally breaks down swallowed DMT.
This interaction makes the preparation pharmacologically different from inhaled DMT. Ingredients and concentrations vary, so ayahuasca is not a standardised product with a single chemical formula.
The Ayahuasca experience
Sensory effects
Visual accounts include vivid patterns, autobiographical scenes and encounters that can feel unusually real. Other people report comparatively little imagery.
Music and singing can shape attention and the emotional direction of an experience. Their role is also cultural and interpersonal, rather than simply an auditory drug effect.
Body sensations
Nausea and vomiting are common. People may also describe strong bodily sensations or changes in physical awareness. Ceremonial interpretations of these effects differ; discomfort does not automatically imply healing.
Headspace
Memories, relationships and difficult emotions can become prominent. Connection, fear, relief and confusion may occur in the same experience. Expectations, the ceremony and relationships with facilitators influence how events are understood afterwards.
Self, time and space
Time may feel extended or lose its familiar structure. Some accounts describe a diminished sense of separation or an unfamiliar relationship with identity. These experiences can carry personal meaning without establishing literal truths about memories or reality.
History and culture
Ayahuasca belongs to diverse Amazonian traditions, rather than a single universal practice. These traditions have changed through exchange, colonisation and the continuing work of Indigenous communities.
Its spread into religious movements, international retreats and research has brought new audiences. It has also raised questions about consent, cultural appropriation, commercialisation and accountability.
Research and uses
Small trials and observational studies have explored depression, wellbeing and patterns of substance use. Some findings are encouraging, but preparation, participant selection and ceremonial context vary substantially.
A reported improvement after a retreat cannot isolate the effects of the brew from expectation, social support or other changes. Longer follow-up and stronger comparisons remain important.
Risks and considerations
MAO-A inhibition creates important interactions with medicines and other drugs, including some that affect serotonin. The risks cannot be inferred from inhaled DMT alone.
Vomiting, cardiovascular effects and severe distress are possible. Screening and consent matter, as do safeguarding and facilitator accountability; ceremonial status does not guarantee a safe environment.
FAQ
Is ayahuasca just oral DMT?
No. The other plant alkaloids alter DMT’s metabolism and add their own pharmacology.
Is every brew the same?
No. Ingredients and strength vary across traditions and providers.
Does a vision reveal a literal truth?
A vision can feel meaningful without being a reliable record of events or a prediction.
5-MeO-DMT
5-Methoxy-N,N-dimethyltryptamine
A brief experience that can profoundly alter the boundary of the self.
5-MeO-DMT is a tryptamine found in some plants and in the secretions of the Sonoran Desert toad. It can also be produced synthetically.
Despite the similar name, it is not another name for DMT. Their effects, pharmacology and risks differ substantially.
5-MeO-DMT at a glance
- Family
- Tryptamines
- Type
- Serotonergic psychedelic
- Primary target
- 5-HT1A and 5-HT2A
- Onset (inhaled)
- Within seconds
- Duration (inhaled)
- Often 10–30 minutes
- Origin
- Plants; toad secretions; synthetic
What is 5-MeO-DMT?
5-MeO-DMT interacts strongly with 5-HT1A and also with 5-HT2A serotonin receptors. That receptor profile differs from a simple description of DMT.
It is broken down partly through MAO-A. Changes to that pathway can alter its effects and risks, making combinations with MAO inhibitors particularly concerning.
The 5-MeO-DMT experience
Sensory effects
Accounts often emphasise a loss of familiar distinctions rather than DMT-like scenes or geometry. Visual effects vary, and elaborate imagery is not required for a profound experience.
Sound is less consistently characterised in research and reports. There is no well-established auditory signature that everyone should expect.
Body sensations
Intense bodily sensations can accompany a rapid change in awareness. The sense of the body may become diffuse or disappear, and the transition can be difficult to describe afterwards.
Headspace
People describe experiences ranging from peace and unity to fear and disorientation. Ordinary thoughts and memories may become difficult to access, leaving an impression that is hard to translate into words.
Self, time and space
A profound loss of the ordinary sense of being a separate person is a recurring theme. Reports use terms such as boundlessness, timelessness and non-duality. These describe subjective experiences or interpretations, rather than a proven explanation of consciousness.
History and culture
5-MeO-DMT was synthesised in the twentieth century and subsequently identified in natural sources. Some plants containing it have histories of Indigenous use, although mixtures may contain other active compounds.
Modern toad-based practices should not automatically be presented as ancient traditions. Their growing popularity also raises questions about animal welfare and wildlife pressure.
Research and uses
Research explores receptor activity, subjective experience and possible mental-health applications. Early findings and clinical development have attracted interest, but the evidence remains less established than publicity sometimes suggests.
Observational reports of improvement cannot separate pharmacology from expectation or support. Studies of a specific formulation also do not establish the safety of toad secretions.
Risks and considerations
Rapid disorientation, loss of responsiveness, vomiting and dangerous physical reactions can occur. MAO inhibitors and other drug combinations can substantially increase risk.
Toad secretions are mixtures rather than purified 5-MeO-DMT. Natural origin does not make them safer, and the brevity of the experience does not make it mild.
FAQ
Is this the same as DMT?
No. The additional methoxy group is associated with major pharmacological and experiential differences.
Does it always have fewer visuals?
Many accounts emphasise changes in selfhood, but visual effects and individual responses vary.
Is toad secretion necessary?
No. Synthetic 5-MeO-DMT exists; the molecule does not require an animal source.
4-AcO-DMT
4-Acetoxy-N,N-dimethyltryptamine
A psilocin-related psychedelic with far more reports than clinical evidence.
4-AcO-DMT, also called psilacetin, is a synthetic tryptamine closely related to psilocin. It is often discussed alongside psilocybin because the compounds share a metabolic connection.
That relationship is useful context, but it does not make mushroom research directly interchangeable with evidence about 4-AcO-DMT.
4-AcO-DMT at a glance
- Family
- Tryptamines
- Type
- Serotonergic psychedelic
- Primary target
- 5-HT2A; psilocin-related activity
- Onset (oral)
- Not well established in trials
- Duration (oral)
- Several hours; limited human data
- Origin
- Synthetic
What is 4-AcO-DMT?
4-AcO-DMT is the acetylated form of psilocin. Laboratory metabolism studies support conversion into psilocin, although its complete activity and time course in humans are not well characterised.
Calling it a psilocin prodrug describes a proposed metabolic role. It does not prove that all its effects, risks or absorption match those of psilocybin.
The 4-AcO-DMT experience
Sensory effects
Firsthand accounts often describe shifting patterns and dreamlike imagery, with frequent comparisons to psilocybin. Controlled comparisons remain scarce.
Changes in music and sound appear in some reports, but there is too little systematic evidence to describe a reliable auditory profile.
Body sensations
Reports include altered bodily sensations, nausea and physical discomfort. Uncertain product identity and limited human research make generalisations difficult.
Headspace
Emotional amplification, introspection and unusual associations recur in accounts. Some people describe connection; others describe anxiety or confusing thought loops. These are reported themes, not predictions.
Self, time and space
Accounts sometimes describe altered time and a less familiar sense of self. The depth and character of these changes are not well established in controlled studies, and mushroom experiences cannot simply be assumed to apply.
History and culture
4-AcO-DMT emerged from twentieth-century tryptamine chemistry and later became known in online psychonaut communities. Its cultural history differs from the long ceremonial histories of mushroom use.
The name psilacetin is sometimes used to distinguish the compound from DMT and other similarly named tryptamines.
Research and uses
Published work includes metabolism and receptor-related studies. There is much less controlled human evidence than for psilocybin.
Its relationship to psilocin makes it scientifically interesting, but therapeutic claims need direct testing. Benefits demonstrated with another compound and clinical protocol cannot simply be transferred to it.
Risks and considerations
Limited evidence leaves uncertainty about short- and long-term risks. Intense distress, impaired judgement and physical adverse effects remain possible.
Unregulated products may contain different compounds or concentrations from those claimed. Sparse research should be read as uncertainty, rather than reassurance.
FAQ
Is it a mushroom extract?
No. 4-AcO-DMT is generally described as a synthetic compound, not ordinary psilocybin mushroom extract.
Is it identical to psilocybin?
No. Both are related to psilocin, but their chemical structures differ.
Why are the timing facts less precise?
Controlled human evidence is limited. Precise-looking ranges would imply more certainty than the evidence supports.
2C-B
4-Bromo-2,5-dimethoxyphenethylamine
A psychedelic often described through colour, sensation and emotional warmth.
2C-B is a synthetic phenethylamine first made by Alexander Shulgin in 1974. It is one of the better-known members of the 2C family.
It has a distinct history in psychonaut and nightlife communities, while controlled research remains relatively limited.
2C-B at a glance
- Family
- Phenethylamines · 2C family
- Type
- Serotonergic psychedelic
- Primary target
- 5-HT2A and related receptors
- Onset (oral)
- Often within 1–2 hours
- Duration (oral)
- Reported 4–8 hours
- Origin
- Synthetic
What is 2C-B?
2C-B acts at serotonin receptors, including 5-HT2A. Its chemical relationship to mescaline helps explain the family resemblance, but does not make their effects identical.
The 2C name refers to the two-carbon chain between the aromatic ring and the amine group. The final letter distinguishes one compound from others in that family.
The 2C-B experience
Sensory effects
People describe intensified colours, patterns and changes in how distances or shapes appear. The prominence of these effects varies.
Music can feel more absorbing in firsthand accounts. Changes in sound should not be assumed to occur in every experience, or to match those of other psychedelics.
Body sensations
Touch and bodily sensations can become more noticeable. Stimulation, physical tension and nausea may accompany pleasant sensations.
Headspace
Emotional openness and excitement appear in reports and small observational studies. Some people describe relatively clear thinking, while others experience confusion or anxiety. Its reputation for being manageable is not a reliable forecast.
Self, time and space
Time and surroundings may feel unfamiliar. Some accounts retain a strong sense of ordinary identity, but this is not guaranteed, and more substantial changes in self-awareness can occur.
History and culture
Shulgin documented 2C-B in his work on psychedelic phenethylamines and in PiHKAL, written with Ann Shulgin. It later circulated more widely beyond those research circles.
The name is now sometimes confused with products sold as tusi or pink cocaine. Those are variable mixtures and should not be assumed to contain 2C-B.
Research and uses
A small observational study of experienced users found changes in perception, mood, heart rate and blood pressure. It was not a placebo-controlled treatment trial.
Such work helps describe acute effects, but does not establish a therapeutic benefit or a complete long-term safety profile.
Risks and considerations
Anxiety, nausea and increases in heart rate or blood pressure are possible. Limited research makes broad claims of safety premature.
Misidentification is a separate concern: 2C-B, NBOMe compounds and products sold as tusi are not interchangeable. Similar names or colours cannot verify composition.
FAQ
Is 2C-B the same as MDMA?
No. Their chemistry and pharmacology differ, even when some descriptions of warmth or stimulation overlap.
Does pink cocaine mean 2C-B?
No. That label commonly describes variable mixtures rather than a verified compound.
Are all 2C compounds similar?
They share a chemical framework, but can differ considerably in intensity, duration and risk.
2C-E
4-Ethyl-2,5-dimethoxyphenethylamine
A long-lasting member of the 2C family, often described as deeply absorbing.
2C-E is a synthetic psychedelic documented by Alexander and Ann Shulgin. Its name resembles 2C-B, but it should be treated as a distinct compound.
Most descriptions of its human effects come from firsthand accounts rather than large controlled studies.
2C-E at a glance
- Family
- Phenethylamines · 2C family
- Type
- Serotonergic psychedelic
- Primary target
- 5-HT2A
- Onset (oral)
- Variable; limited controlled data
- Duration (oral)
- Reported 8–12 hours
- Origin
- Synthetic
What is 2C-E?
2C-E is a substituted phenethylamine. Like other serotonergic psychedelics, its activity involves 5-HT2A receptors, although a receptor label does not describe the whole subjective experience.
The E refers to an ethyl group in the molecule. Small structural changes within the 2C family can produce important differences in effect and duration.
The 2C-E experience
Sensory effects
Published personal accounts describe pronounced visual patterns and altered spatial perception. These observations come mainly from reports rather than controlled human studies.
Sound may feature in sensory accounts, but direct evidence is too limited to define a distinctive auditory effect.
Body sensations
Physical discomfort can be prominent in reports. The long duration may make tension or other unpleasant sensations particularly demanding.
Headspace
Sustained introspection is a recurring theme. Some accounts emphasise emotional depth; others describe a more detached or analytical quality. These conflicting descriptions show why a compound should not be given a fixed experiential personality.
Self, time and space
Space and the passage of time may feel substantially altered. Changes in self-awareness are reported, but their frequency and character are not well quantified.
History and culture
2C-E became known through Shulgin’s exploration of phenethylamines and the publication of PiHKAL. Online communities later contributed further reports and comparisons.
That record is valuable cultural documentation, but it was not collected with the controls or representative sampling of a clinical study.
Research and uses
Research on related receptors and chemical families provides a framework for understanding 2C-E. Direct human research is much more limited.
There is no strong clinical basis for presenting it as a treatment. Reports of insight or personal change are starting points for questions, rather than proof of medical benefit.
Risks and considerations
Severe adverse reactions have been associated with 2C-family compounds, and long-term evidence is limited. Psychological distress, cardiovascular effects and uncertain product identity are important considerations.
Its similarity in name to 2C-B can be misleading. Expectations or assumptions transferred from another compound may not apply.
FAQ
Is 2C-E simply a longer version of 2C-B?
No. They are different molecules; duration is only one difference.
Where does the duration estimate come from?
It is reported in early human accounts, including PiHKAL, rather than established by large clinical trials.
Is an intense experience necessarily beneficial?
No. Intensity does not establish insight, healing or lasting benefit.
2C-I
4-Iodo-2,5-dimethoxyphenethylamine
A less-studied psychedelic associated with visual change and stimulation.
2C-I is a synthetic member of the 2C family. The I refers to iodine in its molecular structure.
It appears in psychonaut writing alongside 2C-B and 2C-E, but its own evidence base is small.
2C-I at a glance
- Family
- Phenethylamines · 2C family
- Type
- Serotonergic psychedelic
- Primary target
- 5-HT2A
- Onset (oral)
- Variable; limited controlled data
- Duration (oral)
- Reported 6–10 hours
- Origin
- Synthetic
What is 2C-I?
2C-I belongs to the substituted phenethylamines and acts at serotonin receptors associated with psychedelic effects. 5-HT2A is a central part of that mechanism.
It is chemically distinct from 25I-NBOMe. The presence of iodine in both names does not make these compounds equivalent.
The 2C-I experience
Sensory effects
Firsthand reports describe enhanced colour and visual patterns. Some emphasise sensory changes more than emotional depth, although this distinction is inconsistent.
Auditory effects are less clearly documented. There is not enough controlled evidence to describe a dependable pattern of changes to sound.
Body sensations
A noticeable stimulating quality is often reported. Tension, nausea and unfamiliar bodily sensations may accompany the perceptual effects.
Headspace
Attention and associations can feel unusual. Accounts include excitement as well as anxiety, but the small evidence base makes confident comparisons with 2C-B or 2C-E unreliable.
Self, time and space
Time perception may change, and surroundings can feel unfamiliar. More detailed claims about identity or ego dissolution rest on limited accounts rather than a well-established human profile.
History and culture
2C-I was documented in PiHKAL as part of the Shulgins’ exploration of phenethylamines. Its later circulation helped bring it into online discussion of less familiar psychedelics.
The resulting archive contains useful observations, but often lacks verified identity, medical follow-up or a consistent way of recording effects.
Research and uses
Laboratory studies of receptor activity help explain why compounds in this family can alter perception. That is different from demonstrating a safe or effective human treatment.
Evidence about long-term outcomes and therapeutic applications of 2C-I remains limited. Findings from other psychedelics cannot fill every gap.
Risks and considerations
Physical stimulation may include increased heart rate and blood pressure. Distress, confusion and other adverse reactions are possible, with limited evidence to quantify their frequency.
Confusion with similarly named compounds is particularly important. 25I-NBOMe has a different potency and risk profile, and visual appearance cannot distinguish them reliably.
FAQ
Is 2C-I the same as 25I-NBOMe?
No. They are distinct molecules with materially different pharmacology and risks.
Does iodine make it radioactive?
No. The presence of iodine in a chemical name does not imply radioactivity.
How certain are descriptions of its effects?
They rely heavily on personal accounts and limited research, so confident comparisons deserve caution.
DOM
2,5-Dimethoxy-4-methylamphetamine
A psychedelic whose unusually long duration is central to its story.
DOM is a synthetic psychedelic in the substituted amphetamine family, often grouped with the DOx compounds. It was also known historically as STP.
Its chemical family name can be confusing: DOM is discussed here for its psychedelic effects, not as another name for ordinary amphetamine.
DOM at a glance
- Family
- Substituted amphetamines · DOx
- Type
- Serotonergic psychedelic
- Primary target
- 5-HT2A
- Onset (oral)
- Slow; can take several hours
- Duration (oral)
- Reported 14–20 hours
- Origin
- Synthetic
What is DOM?
DOM acts at serotonin receptors, including 5-HT2A, producing psychedelic effects. Its structure includes the amphetamine backbone, but chemical family alone does not determine a drug’s full action.
Its slow development and extended duration distinguish it from many better-known psychedelics.
The DOM experience
Sensory effects
Early accounts describe pronounced visual patterns and sustained changes in perception. The effects can develop slowly before becoming much more prominent.
Changes to sound are less systematically documented than the broader psychedelic effects. A consistent auditory profile has not been established.
Body sensations
A stimulating physical quality is commonly described. Over a long experience, tension, restlessness and fatigue may become particularly noticeable.
Headspace
Changes in thought can be absorbing, emotionally significant or confusing. Fascination and fear may coexist, and a slow beginning does not predict the eventual intensity.
Self, time and space
The experience can alter the sense of time while lasting many hours by the clock. Changes in self-awareness may also occur, but descriptions vary and controlled human evidence is limited.
History and culture
Alexander Shulgin developed DOM during his exploration of psychedelic phenethylamines. It entered the 1960s counterculture under the name STP.
Historical accounts of unexpectedly difficult experiences highlight confusion about strength and delayed onset. Those events shaped its reputation as much as descriptions of the psychedelic effects themselves.
Research and uses
DOM has been used in laboratory research on serotonergic psychedelic activity. Such work helps connect chemical structure, receptors and behaviour.
That research role should not be confused with an established therapeutic use. Contemporary controlled evidence about human benefits and long-term outcomes is limited.
Risks and considerations
Its slow onset can lead people to underestimate how much the effects are still developing. Its long duration adds risks related to exhaustion, distress and prolonged impairment.
Cardiovascular stimulation and severe psychological reactions are possible. Applying assumptions from shorter-acting compounds is particularly unreliable.
FAQ
Is DOM an ordinary stimulant?
No. Despite its substituted amphetamine structure, it has prominent psychedelic effects.
What does STP refer to?
It is a historical name associated with DOM’s circulation in the 1960s.
Is the duration fixed?
No. The reported range is approximate, with substantial individual and circumstance-dependent variation.
Ketamine
A dissociative anaesthetic
A shift in the connection between body, surroundings and awareness.
Ketamine is a medicine used in anaesthesia and pain care, and a compound used outside medicine for its dissociative effects. Related treatments have also become important in depression care.
It works differently from classic psychedelics. Detachment from the body or environment is often more central than the patterned visual changes associated with LSD.
Ketamine at a glance
- Family
- Arylcyclohexylamines
- Type
- Dissociative anaesthetic
- Primary target
- NMDA receptor blockade
- Onset
- Route-dependent
- Duration
- Route-dependent; impairment may persist
- Origin
- Synthetic
What is Ketamine?
Ketamine blocks NMDA receptors, which respond to the brain’s messenger glutamate. Its wider effects involve changes in signalling across networks; NMDA blockade is the starting point, not a complete explanation.
Ketamine contains two mirror-image forms. Esketamine is one of these, used in specific medical products. A regulated treatment is not equivalent to an unregulated product with the same general name.
The Ketamine experience
Sensory effects
Vision and the sense of distance may change. More immersive dissociation can involve elaborate internal scenes or a loss of contact with the visible room.
Sounds may seem distant, distorted or disconnected from their source. The relationship between hearing and the surrounding space can feel unfamiliar.
Body sensations
Floating, numbness and distance from the body are frequently described. Movement and coordination may be difficult even while thoughts remain active.
Headspace
Thought can become dreamlike or fragmented. The experience may feel peaceful, strange or frightening, with gaps in memory and difficulty making sense of events afterwards.
Self, time and space
Ordinary space, time and identity may become difficult to locate. The informal term K-hole refers to intense dissociation, but does not define one precise or universal state.
History and culture
Ketamine was developed in the 1960s and adopted as an anaesthetic. Its clinical usefulness and its nonmedical use developed in different settings.
More recently, interest in rapid antidepressant effects has changed public discussion. This medical story coexists with established nightlife and psychonaut cultures.
Research and uses
Ketamine has established anaesthetic uses. It is also used off-label for depression in some settings, while esketamine has specific regulatory approvals. These distinctions matter.
Clinical care involves assessment, monitoring and follow-up. Treatment findings do not show that unsupervised use produces the same benefits or carries the same risks.
Risks and considerations
Impaired coordination and awareness create injury risks. Combining ketamine with alcohol, opioids or other sedatives can increase dangerous sedation and breathing problems.
Repeated heavy use can cause serious bladder and urinary-tract damage. Dependence, compulsive use and cognitive difficulties are also concerns, which distinguish its risk profile from that of many classic psychedelics.
FAQ
Is ketamine a classic psychedelic?
No. It is a dissociative, with a different main receptor mechanism.
Is esketamine identical to ketamine?
Esketamine is one mirror-image component of ketamine; products and treatment protocols differ.
Does a medical use mean recreational use is safe?
No. The formulation, screening, monitoring and context are different.
DXM
Dextromethorphan
A cough suppressant with very different effects outside its medical use.
DXM is an ingredient in some cough medicines. At higher exposures it can produce dissociation, altered perception and substantial impairment.
The medicine label and the dissociative experience describe different contexts. Common availability does not make nonmedical use predictable.
DXM at a glance
- Family
- Morphinans
- Type
- Cough suppressant; dissociative
- Primary target
- NMDA blockade, chiefly via dextrorphan
- Onset (oral)
- Varies with formulation
- Duration (oral)
- Several hours; sometimes longer
- Origin
- Synthetic
What is DXM?
The body converts DXM into dextrorphan, which blocks NMDA receptors. DXM also affects other systems, including serotonin signalling and sigma-1 receptors.
The enzyme CYP2D6 influences how it is processed. Genetic differences and medicines that affect this enzyme can change the balance of effects and their duration.
The DXM experience
Sensory effects
Accounts describe altered visual perception and dreamlike imagery. At stronger intensity, confusion and reduced contact with surroundings can dominate.
Sound may feel distorted or unusually distant. Music can become central to an account, but auditory changes are variable rather than predictable.
Body sensations
Distance from the body and altered movement are common report themes. Coordination and speech may be impaired, and nausea or uncomfortable sensations can occur.
Headspace
Thoughts may feel dreamlike, disconnected or difficult to follow. Accounts range from absorption to agitation and confusion. Informal online plateaus do not reliably predict an individual experience.
Self, time and space
Time, location and bodily identity may become unfamiliar during dissociation. The character and duration of these changes vary with metabolism, formulation and other circumstances.
History and culture
DXM entered cough medicines in the twentieth century. Its dissociative use later developed a substantial online culture, including detailed experience reports.
That culture helped make an unfamiliar effect accessible to readers, but it also encouraged simplified categories that can obscure individual differences and product ingredients.
Research and uses
DXM has established use as a cough suppressant. Specific prescription combinations also use its pharmacology for other conditions, including some neurological symptoms and depression.
Those products combine controlled formulations with medical assessment. Their evidence does not establish a benefit from using cough medicines to seek dissociation.
Risks and considerations
Serotonin toxicity is a serious interaction concern, especially with MAO inhibitors and other serotonergic drugs. Severe confusion, overheating, seizures and other medical emergencies can occur.
Cough products may contain additional ingredients, such as paracetamol, antihistamines or decongestants, with their own toxicity. A product containing DXM is not necessarily DXM alone.
FAQ
Is DXM the same as an opioid painkiller?
No. Its structure is related to morphinans, but its usual pharmacology differs from opioid pain medicines.
Do all cough medicines contain only DXM?
No. Many are combination products with additional active ingredients.
Why can effects vary so much?
Metabolism, formulation, interactions and individual biology all affect the response.
MDMA
3,4-Methylenedioxymethamphetamine
An altered state centred on emotional openness, connection and heightened sensation.
MDMA is a synthetic compound often associated with feelings of closeness, empathy and increased energy. It is commonly described as an empathogen or entactogen, rather than a classic psychedelic.
Its story connects dance music, personal exploration and research into psychotherapy. These settings involve the same molecule, but very different expectations and experiences.
MDMA at a glance
- Family
- Substituted amphetamines
- Type
- Empathogen / entactogen
- Primary target
- Monoamine transporters
- Onset (oral)
- Typically within an hour
- Duration (oral)
- Several hours
- Origin
- Synthetic
What is MDMA?
MDMA increases the activity of serotonin, noradrenaline and dopamine by affecting their transporters and promoting their release. These chemical messengers influence mood, arousal and other functions.
Unlike classic psychedelics, its main mechanism is not direct activation of the 5-HT2A receptor. Emotional and social changes are often more prominent than elaborate visual experiences.
The MDMA experience
Sensory effects
Surroundings can seem more vivid or engaging. Visual changes can occur, but intricate patterns and immersive scenes are not usually the central feature of an MDMA experience.
Music may feel especially absorbing, with rhythm and sound taking on emotional significance. The setting and personal associations with the music also shape that response.
Body sensations
Touch can feel more intense or pleasurable, alongside increased energy and warmth. Jaw tension, sweating, nausea or other discomfort may also occur.
Headspace
People often describe affection, openness and a stronger sense of connection with others. Difficult feelings may seem easier to discuss, although anxiety and confusion remain possible. Feeling unusually trusting does not establish that another person is trustworthy.
Self, time and space
Time perception may shift, while familiar surroundings and personal identity often remain more recognisable than in an immersive classic psychedelic experience. Connection with others need not involve ego dissolution.
History and culture
MDMA was first synthesised at Merck in 1912. Decades later, interest in its psychological effects brought it into some psychotherapy circles.
It became closely associated with club and rave culture during the 1980s and beyond. Those cultural associations coexist with quieter personal settings and clinical research.
Research and uses
Researchers have investigated MDMA as an adjunct to psychotherapy, particularly for post-traumatic stress disorder. A 2023 phase III trial involving 104 participants reported greater symptom improvement with MDMA-assisted therapy than with placebo plus the same therapy.
The findings concern a structured treatment with screening, preparation and follow-up. The noticeable effects make blinding difficult, and trial results do not show that recreational use provides the same benefits. Questions about durability, safety and the contribution of the therapy remain important.
Risks and considerations
MDMA can raise body temperature, heart rate and blood pressure. Overheating can be dangerous, especially with exertion in hot environments. Both dehydration and excessive water intake can cause serious harm.
Drug interactions, particularly with MAO inhibitors, can be dangerous. Sleep disruption, low mood and anxiety may occur afterwards. Products sold as ecstasy or molly can contain other compounds, so a name or appearance cannot establish their contents.
FAQ
Is MDMA a classic psychedelic?
No. It is usually described as an empathogen or entactogen, with stimulant and sensory effects. It appears here alongside other compounds that differ from classic psychedelics.
Are ecstasy and molly always MDMA?
They are common street names, not reliable guarantees of chemical identity or purity.
Does feeling connected mean an experience is therapeutic?
Not necessarily. A positive feeling and a lasting clinical benefit are different things, and medical studies include support beyond the compound itself.
Sources
- EUDA: MDMA drug profile.
- NIDA: MDMA research report.
- MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial (2023).
- Ecstasy, molly, MDMA: What health practitioners need to know about this common recreational drug (2025).
- PubChem: MDMA molecular identity.
- EUDA: MDMA retail markets and associated harms.
Salvia
Salvia divinorum · active compound: salvinorin A
A strikingly unfamiliar alteration of body, place and identity.
Salvia divinorum is a plant in the mint family. Its main psychoactive constituent, salvinorin A, acts differently from both classic psychedelics and ketamine.
The plant and the isolated compound are not identical, and traditional leaf use differs from modern concentrated extracts.
Salvia at a glance
- Family
- Salvinorin A: diterpenoid
- Type
- Atypical hallucinogen
- Primary target
- Kappa-opioid receptor
- Onset (inhaled)
- Within seconds
- Duration (inhaled)
- Often 5–20 minutes
- Origin
- Salvia divinorum
What is Salvia?
Salvinorin A activates the kappa-opioid receptor, rather than relying on the 5-HT2A pathway of classic psychedelics. It is a diterpenoid and contains no nitrogen, unlike many familiar psychoactive alkaloids.
The word opioid here identifies a receptor family. It does not mean salvia produces the same effects as morphine or other familiar opioid medicines.
The Salvia experience
Sensory effects
Familiar surroundings may seem replaced by another scene. Accounts can involve repetition or the impression of becoming part of an object or surface, rather than conventional psychedelic patterns.
Sounds or voices may seem altered or become woven into the experience. Auditory descriptions vary and are not as consistently characterised as the changes in body and space.
Body sensations
Pulling, turning and changes in apparent body shape recur in firsthand reports. Bodily orientation may become difficult to recognise, with little awareness of ordinary surroundings.
Headspace
The abrupt shift can be bewildering or frightening rather than pleasurable. Some experiences are difficult to remember or describe, and familiar explanations may only return afterwards.
Self, time and space
A sudden change in identity or location is a recurring theme. People may feel they are somewhere else or part of something other than their usual body. A short experience by the clock can feel much more extensive.
History and culture
Salvia has a history of use among Mazatec communities in Mexico, including healing and divinatory settings. The practices and meanings belong to that cultural context.
Modern use of concentrated extracts and their circulation online are a different development. Viral videos provide a particularly narrow and often misleading view of the plant.
Research and uses
Salvinorin A interests researchers because it can produce profound perceptual changes through an unusual receptor mechanism. Controlled studies have examined its subjective effects and physiology.
Laboratory interest in the kappa-opioid system does not establish salvia as a treatment. Evidence about long-term outcomes remains limited.
Risks and considerations
Loss of awareness of the room and uncontrolled movement create a risk of accidental injury. Panic, confusion and unpleasant bodily sensations may occur rapidly.
Extract strength is variable, and effects differ with how the plant or compound is encountered. Limited long-term evidence should not be mistaken for proof of harmlessness.
FAQ
Is salvia the same as culinary sage?
No. This guide refers specifically to Salvia divinorum, not ordinary cooking sage.
Is it a classic psychedelic?
No. Its principal active compound acts mainly at kappa-opioid receptors.
Why show salvinorin A’s molecule?
Salvia is a plant, not one molecule. Salvinorin A is its main psychoactive constituent.
Tryptamines
Experiences
A place to explore what psychedelics can feel like, from changes in perception to shifts in your sense of self.
Experiences
Ego dissolution
What do people mean when they say they lost their sense of self?
Talking about the experience
When someone tells their story, what changed in how they felt about themselves or their surroundings? How did they make sense of it afterwards?
Psychedelic culture
History and traditions
Ceremonial traditions, counterculture, and the ways people have talked about psychedelics over time.
Art and music
How artists, musicians, and filmmakers have tried to capture the experience.
Communities
How people find each other, share what they’ve learned, and make sense of experiences together.
Explore community discussions →